Mozambique vs Solomon Islands: Previously treated cases tested for RR-/MDR-TB
Mozambique
25.0%
in 2024
Solomon Islands
9.1%
in 2024
Mozambique rank
164th
Solomon Islands rank
167th
Previously treated cases tested for RR-/MDR-TB over time
- Mozambique
- Solomon Islands
How they compare
Mozambique currently reports 25.0% against 9.1% in Solomon Islands, a difference of 15.9%.
That makes Mozambique's figure about 2.7 times Solomon Islands's.
The two have swapped places 7 times across 17 shared years of data; in 2006 it was Solomon Islands ahead.
Mozambique ranks 164th and Solomon Islands ranks 167th of 180 countries.
Across the 3 decades both report, Mozambique averaged higher in 1 and Solomon Islands in 2.
Head to head by decade
| Decade | Mozambique | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.0% | 100.0% | 93.0% | Solomon Islands |
| 2010s | 30.4% | 30.4% | 0.0% | Solomon Islands |
| 2020s | 72.4% | 45.2% | 27.2% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Mozambique or Solomon Islands?
- Mozambique, at 25.0% against 9.1% in Solomon Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Mozambique and Solomon Islands?
- 15.9%, with Mozambique ahead.
- How many years of comparable data are there for Mozambique and Solomon Islands?
- 17 years are reported by both, from 2006 to 2024.
- How do Mozambique and Solomon Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Mozambique ranks 164th and Solomon Islands ranks 167th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.